
In the evolving landscape of regenerative medicine, OptyBone represents a paradigm shift in xenograft technology. By combining natural equine bone architecture with the patented EstRem™ process, it delivers a scaffold that is not only osteoconductive but biologically superior.
The core of OptyBone’s success is the EstRem™ (Esterification Cell-Removal) technology. This advanced biochemical process ensures the total removal of cellular components while meticulously preserving the natural collagen matrix and signaling growth factors that are often lost in high-heat processing.
OptyBone maintains the natural porous structure of equine bone, which is highly similar to human bone. This macro and micro-porosity allows for rapid angiogenesis and deep penetration of osteoblasts, leading to high-quality, vital bone formation.
OptyBone is not a one-size-fits-all solution. Its ecosystem is engineered to provide different resorption profiles depending on the clinical requirement, from rapid turnover to long-term volume maintenance.
In the world of regenerative dentistry, OptyBone represents the pinnacle of biomaterial engineering. It is not simply a bone filler; it is a bioactive scaffold designed to mirror human physiology.
The secret to its performance lies in patented EstRem™ Technology. Unlike conventional grafts, this process ensures the total removal of immunogens while preserving native collagen and bone architecture. This leads to faster healing and high-density bone formation in every clinical scenario.